SEC filing · 10-K

Rezolute, Inc.: Annual report

Rezolute reported a net loss of $77.6 million for fiscal year 2026 while advancing clinical studies and maintaining $107.8 million in capital resources.

Filed September 24, 2026 · period ended June 30, 2026

Mixed for the company

What the numbers say

Diluted EPS -$0.75 versus -$0.98; operating cash flow -$64.6M (a year earlier -$69.1M); cash fell by $83.5M to $10.6M; diluted share count up 37% (dilution).

Compared with the same period a year earlier, from the figures Rezolute, Inc. reported to the SEC.

What happened

The company did not generate revenue and recorded a net loss of $77.6 million for the fiscal year ended June 30, 2026.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Rezolute, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.